Schizophrenia Research
Volume 119, Issue 1 , Pages 198-209 , June 2010

Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia

  • L.V. Kristiansen

      Affiliations

    • Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
    • Corresponding Author InformationCorresponding author. European Science Foundation, 1 Quai Lezai-Marnésia 67080 Strasbourg Cedex, France. Tel.: +33 658631018, fax: +33 388 370532.
    • ,
  • B. Bakir

      Affiliations

    • Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA
    • ,
  • V. Haroutunian

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, Bronx VA Medical Center, Bronx, NY 10468, USA
    • ,
  • J.H. Meador-Woodruff

      Affiliations

    • Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA

Received 24 September 2009 ,Accepted 25 February 2010.

References 

  1. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 1996;16(1):19–30
  2. Atasoy D, Schoch S, Ho A, Nadasy KA, Liu X, Zhang W, et al Deletion of CASK in mice is lethal and impairs synaptic function. Proc. Natl. Acad. Sci. U. S. A. 2007;104(7):2525–2530
  3. Beasley CL, Reynolds GP. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 1997;24(3):349–355
  4. Behrendt RP. Dysregulation of thalamic sensory “transmission” in schizophrenia: neurochemical vulnerability to hallucinations. J. Psychopharmacol. 2006;20(3):356–372
  5. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology. 2007;32(9):1888–1902
  6. Benshalom G, White EL. Quantification of thalamocortical synapses with spiny stellate neurons in layer IV of mouse somatosensory cortex. J. Comp. Neurol. 1986;253(3):303–314
  7. Beresewicz M. Scaffold proteins (MAGUK, Shank and Homer) in postsynaptic density in the central nervous system. Postepy Biochem. 2007;53(2):188–197
  8. Biederer T, Sudhof TC. Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J. Biol. Chem. 2000;275(51):39,803–39,806
  9. Bloomfield C, French SJ, Jones DN, Reavill C, Southam E, Cilia J, et al. Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats. Synapse. 2008;62(8):628–631
  10. Boyce-Rustay JM, Holmes A. Functional roles of NMDA receptor NR2A and NR2B subunits in the acute intoxicating effects of ethanol in mice. Synapse. 2005;56(4):222–225
  11. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254
  12. Chen Q, He S, Hu XL, Yu J, Zhou Y, Zheng J, et al. Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J. Neurosci. 2007;27(3):542–552
  13. Chu PJ, Rivera JF, Arnold DB. A role for Kif17 in transport of Kv4.2. J. Biol. Chem. 2006;281(1):365–373
  14. Clinton SM, Meador-Woodruff JH. Nucleus-specific expression of NMDA receptor-associated postsynaptic density proteins in primate thalamus. Thalamus Relat. Sys. 2002;1(4):303–316
  15. Clinton SM, Meador-Woodruff JH. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology. 2004;29(7):1353–1362
  16. Clinton SM, Meador-Woodruff JH. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr. Res. 2004;69(2–3):237–253
  17. Cousins SL, Papadakis M, Rutter AR, Stephenson FA. Differential interaction of NMDA receptor subtypes with the post-synaptic density-95 family of membrane associated guanylate kinase proteins. J. Neurochem. 2008;104(4):903–913
  18. Coyle JT. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 2004;68(8):1507–1514
  19. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 2001;11(3):327–335
  20. Cuthbert PC, Stanford LE, Coba MP, Ainge JA, Fink AE, Opazo P, et al. Synapse-associated protein 102/dlgh3 couples the NMDA receptor to specific plasticity pathways and learning strategies. J. Neurosci. 2007;27(10):2673–2682
  21. Duffy S, Labrie V, Roder JC. d-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacology. 2008;33(5):1004–1018
  22. Ford JM, Mathalon DH. Neural synchrony in schizophrenia. Schizophr. Bull. 2008;34(5):904–906
  23. Freund TF, Martin KA, Soltesz I, Somogyi P, Whitteridge D. Arborisation pattern and postsynaptic targets of physiologically identified thalamocortical afferents in striate cortex of the macaque monkey. J. Comp. Neurol. 1989;289(2):315–336
  24. Garey LJ, Von Bussmann KA, Hirsch SR. Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics. Exp. Brain Res. 2006;173(2):234–242
  25. Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp. 2005;25(1):60–69
  26. Gray JA, Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr. Bull. 2007;33(5):1100–1119
  27. Guillaud L, Setou M, Hirokawa N. KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons. J. Neurosci. 2003;23(1):131–140
  28. Guillaud L, Wong R, Hirokawa N. Disruption of KIF17-Mint1 interaction by CaMKII-dependent phosphorylation: a molecular model of kinesin-cargo release. Nat. Cell Biol. 2008;10(1):19–29
  29. Halim ND, Weickert CS, McClintock BW, Hyde TM, Weinberger DR, Kleinman JE, et al. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol. Psychiatry. 2003;8(9):797–810
  30. Hanaoka T, Toyoda H, Mizuno T, Kikuyama H, Morimoto K, Takahata R, et al. Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs. Neurochem. Res. 2003;28(6):919–924
  31. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 1995;200(3):151–154
  32. Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J. Neural. Transm. 2007;114(7):893–898
  33. Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am. J. Psychiatry. 2008;165(4):479–489
  34. Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiatry. 2002;59(7):631–640
  35. Hendry SH, Jones EG, Emson PC, Lawson DE, Heizmann CW, Streit P. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp. Brain Res. 1989;76(2):467–472
  36. Hilbig H, Bidmon HJ, Oppermann OT, Remmerbach T. Influence of post-mortem delay and storage temperature on the immunohistochemical detection of antigens in the CNS of mice. Exp. Toxicol. Pathol. 2004;56(3):159–171
  37. Hirokawa N, Takemura R. Kinesin superfamily proteins and their various functions and dynamics. Exp. Cell Res. 2004;301(1):50–59
  38. Ho A, Morishita W, Hammer RE, Malenka RC, Sudhof TC. A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission. Proc. Natl. Acad. Sci. U. S. A. 2003;100(3):1409–1414
  39. Hsueh YP. The role of the MAGUK protein CASK in neural development and synaptic function. Curr. Med. Chem. 2006;13(16):1915–1927
  40. Hynd MR, Scott HL, Dodd PR. Quantitation of NMDA receptor NR2 mRNA transcripts in human brain by competitive RT-PCR. Brain Res. Brain Res. Protoc. 2003;11(1):67–79
  41. Ibrahim HM, Healy DJ, Hogg AJ, Meador-Woodruff JH. Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus. Brain Res. Mol. Brain Res. 2000;79(1–2):1–17
  42. Ibrahim HM, Hogg AJ, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry. 2000;157(11):1811–1823
  43. Iwamoto T, Yamada Y, Hori K, Watanabe Y, Sobue K, Inui M. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins. J. Neurochem. 2004;89(1):100–108
  44. Janssen WG, Vissavajjhala P, Andrews G, Moran T, Hof PR, Morrison JH. Cellular and synaptic distribution of NR2A and NR2B in macaque monkey and rat hippocampus as visualized with subunit-specific monoclonal antibodies. Exp. Neurol. 2005;191(Suppl 1):S28–S44
  45. Kayadjanian N, Lee HS, Pina-Crespo J, Heinemann SF. Localization of glutamate receptors to distal dendrites depends on subunit composition and the kinesin motor protein KIF17. Mol. Cell. Neurosci. 2007;34(2):219–230
  46. Kim MJ, Dunah AW, Wang YT, Sheng M. Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron. 2005;46(5):745–760
  47. Konradi C, Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol. Psychiatry. 2001;50(10):729–742
  48. Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry. 2006;11(8):737–747
  49. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH. NMDA receptors and schizophrenia. Curr. Opin. Pharmacol. 2007;7(1):48–55
  50. Law AJ, Weickert CS, Webster MJ, Herman MM, Kleinman JE, Harrison PJ. Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation. Eur. J. NeuroSci. 2003;18(5):1197–1205
  51. Le Corre S, Harper CG, Lopez P, Ward P, Catts S. Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia. NeuroReport. 2000;11(5):983–986
  52. Lee KH, Williams LM, Breakspear M, Gordon E. Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res. Brain Res. Rev. 2003;41(1):57–78
  53. Leveque JC, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, et al Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci. 2000;20(11):4011–4020
  54. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch. Neurol. 2006;63(10):1372–1376
  55. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005;6(4):312–324
  56. Lindsley CW, Shipe WD, Wolkenberg SE, Theberge CR, Williams DL, Sur C, et al. Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr. Top. Med. Chem. 2006;6(8):771–785
  57. Loftis JM, Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol. Ther. 2003;97(1):55–85
  58. Lubke J, Egger V, Sakmann B, Feldmeyer D. Columnar organization of dendrites and axons of single and synaptically coupled excitatory spiny neurons in layer 4 of the rat barrel cortex. J. Neurosci. 2000;20(14):5300–5311
  59. Miller JA. The calibration of 35S or 32P with 14C-labeled brain paste or 14C-plastic standards for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm. Neurosci. Lett. 1991;121(1–2):211–214
  60. Misawa H, Kawasaki Y, Mellor J, Sweeney N, Jo K, Nicoll RA, et al. Contrasting localizations of MALS/LIN-7 PDZ proteins in brain and molecular compensation in knockout mice. J. Biol. Chem. 2001;276(12):9264–9272
  61. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 1998;54(5):581–618
  62. Pratt JA, Winchester C, Egerton A, Cochran SM, Morris BJ. Modelling prefrontal cortex deficits in schizophrenia: implications for treatment. Br. J. Pharmacol. 2008;153(Suppl 1):S465–S470
  63. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, et al. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol. Psychiatry. 1993;33(4):255–260
  64. Ragland JD, Yoon J, Minzenberg MJ, Carter CS. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism. Int. Rev. Psychiatry. 2007;19(4):417–427
  65. Scarr E, Beneyto M, Meador-Woodruff JH, Deans B. Cortical glutamatergic markers in schizophrenia. Neuropsychopharmacology. 2005;30(8):1521–1531
  66. Sessoms-Sikes S, Honse Y, Lovinger DM, Colbran RJ. CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation-dependent mechanism. Mol. Cell. Neurosci. 2005;29(1):139–147
  67. Setou M, Nakagawa T, Seog DH, Hirokawa N. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science. 2000;288(5472):1796–1802
  68. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 1994;368(6467):144–147
  69. Siew LK, Love S, Dawbarn D, Wilcock GK, Allen SJ. Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay. J. Neurosci. Meth. 2004;139(2):153–159
  70. Somogyi P, Tamas G, Lujan R, Buhl EH. Salient features of synaptic organisation in the cerebral cortex. Brain Res. Brain Res. Rev. 1998;26(2–3):113–135
  71. Staiger JF, Zilles K, Freund TF. Distribution of GABAergic elements postsynaptic to ventroposteromedial thalamic projections in layer IV of rat barrel cortex. Eur. J. NeuroSci. 1996;8(11):2273–2285
  72. Staiger JF, Flagmeyer I, Schubert D, Zilles K, Kotter R, Luhmann HJ. Functional diversity of layer IV spiny neurons in rat somatosensory cortex: quantitative morphology of electrophysiologically characterized and biocytin labeled cells. Cereb. Cortex. 2004;14(6):690–701
  73. Stephenson FA. Subunit characterization of NMDA receptors. Curr. Drug Targets. 2001;2(3):233–239
  74. Stratford KJ, Tarczy-Hornoch K, Martin KA, Bannister NJ, Jack JJ. Excitatory synaptic inputs to spiny stellate cells in cat visual cortex. Nature. 1996;382(6588):258–261
  75. Takai H, Katayama K, Uetsuka K, Nakayama H, Doi K. Distribution of N-methyl-d-aspartate receptors (NMDARs) in the developing rat brain. Exp. Mol. Pathol. 2003;75(1):89–94
  76. Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Mol. Psychiatry. 2005;10(1):27–39
  77. Tran DH, Gong R, Tang SJ. Differential roles of NR2A and NR2B subtypes in NMDA receptor-dependent protein synthesis in dendrites. Neuropharmacology. 2007;53(2):252–256
  78. Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M, Lewis DA, et al. A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J. Neurosci. 2008;28(48):12,691–12,699
  79. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, et al Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron. 1999;23(3):583–592
  80. White EL. Reflections on the specificity of synaptic connections. Brain Res. Rev. 2007;55(2):422–429
  81. Winterer G. Cortical microcircuits in schizophrenia—the dopamine hypothesis revisited. Pharmacopsychiatry. 2006;39(Suppl 1):S68–S71
  82. Wong RW, Setou M, Teng J, Takei Y, Hirokawa N. Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2002;99(22):14,500–14,505
  83. Xu F, Plummer MR, Len GW, Nakazawa T, Yamamoto T, Black IB, et al. Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation. Brain Res. 2006;1121(1):22–34
  84. Yashiro K, Philpot BD. Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology. 2008;55(7):1081–1094
  85. Yuen EY, Jiang Q, Feng J, Yan Z. Microtubule regulation of N-methyl-d-aspartate receptor channels in neurons. J. Biol. Chem. 2005;280(33):29,420–29,427
  86. Zhao JP, Constantine-Paton M. NR2A−/− mice lack long-term potentiation but retain NMDA receptor and L-type Ca2+ channel-dependent long-term depression in the juvenile superior colliculus. J. Neurosci. 2007;27(50):13,649–13,654
  87. Zhou Y, Takahashi E, Li W, Halt A, Wiltgen B, Ehninger D, et al. Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning. J. Neurosci. 2007;27(50):13,843–13,853

PII: S0920-9964(10)01164-3

doi: 10.1016/j.schres.2010.02.1069

Schizophrenia Research
Volume 119, Issue 1 , Pages 198-209 , June 2010

Article Tools

* Image Usage & Resolution